HealthStock News
Cerenome reports US$0.7M CNSide revenue with trial data due in 2027
The US$20M facility carries interest and royalties, with future funding conditional ahead of mid-2027 cancer trial readouts.
Organigram gets Nasdaq bid‑price notice with May 2027 deadline
Trading continues on Nasdaq and the TSX as the cannabis producer faces a consecutive-day bid-price test to regain compliance.
MiningGold
Asante Gold withdraws guidance as quarterly costs reach US$4,860 an ounce
The Ghana producer faces a Nov. 30 deadline to secure at least US$100 million in new funding and plans a January turnaround update.
Analysis
Amylyx Pharmaceuticals details 55% hypoglycemia reduction in Phase 3
New controlled event rates expand the avexitide readout, while the company still targets a year-end FDA application.
Technology
NASDAQ: BTDRBitdeer reports 256.1 BTC in weekly sales and zero pure holdings
The balance excludes customer deposits, and the weekly post discloses no sale proceeds or average execution price.
EnergyTechnology
Fermi signs US$200M prepayment agreement for 600 MW Texas development
The Financial Times identifies Amazon as the customer, while Fermi says a definitive long-term lease remains under negotiation.
HealthStock News
Tandem Diabetes Care wins FDA clearance for tubeless Mobi set worn up to 7 days
The new supplies work with existing pumps, with a U.S. launch planned for the first half of 2027 and access limited to pharmacy benefits.
Health
CPH: NOVO-BThe applications follow a Phase 3 trial showing 27 per cent fewer painful crises versus placebo, with regulatory action expected in 2027.
Health
NASDAQ: ALLRA one-time gain is expected to exceed fourth-quarter operating expenses, while full-year guidance still calls for a loss.
Analysis
Twenty One Capital reports US$1.09B bitcoin gain and US$102.8M cash
Convertible-note principal stood at US$486.5 million, with about 16,116 bitcoin pledged as the company evaluates operating businesses.
Latest
AVAX One drops Alberta data-centre plan to focus on AVAX treasury
The Alberta proposal carried an estimated US$30M to US$35M cost, while token revaluation drove the quarterly profit.
USGS projects tungsten capacity growth of at least 10 per cent by 2030
Natural graphite capacity could grow 20 per cent as China retains its dominance and Western tungsten projects face commissioning milestones.
Veolia launches French battery-metals plant with nearly 7,000‑tonne capacity
The Grand Est site will recover cobalt, nickel and copper from black mass, but Veolia disclosed no investment cost or earnings forecast.
GoldHaven Resources reports 8,850 ppm tungsten in Magno rock sample
Selective sampling identified a new skarn target south of Lamb Mountain, but GoldHaven has not dated follow-up work.
Omineca Mining and Metals signs Wingdam gold JV letter with HMI
Omineca would retain a 50 per cent carried interest and receive half the recovered gold at a base cost of C$1,000 an ounce.
enCore Energy reports Q3 gross loss as uranium sales costs rise
Uranium sales costs averaged US$87.22 per pound, while the producer awaits Texas approvals for extraction targets before year-end.
Mentioned this week
Mining & Critical Minerals
Gold, silver, uranium, lithium, copper and rare earths: the producers, the developers and the projects behind them.
View all
MiningStock News
Northern Graphite clears US$23.6M debt in Sprott restructuring
The lender becomes its largest shareholder with 9.9 per cent, while the Okanjande stream expands to cover all future production.
Health & Science
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
View all
Health
NASDAQ: MISTSeptember liquidity of US$145.4 million is forecast to last into late 2028, beyond the expected ReVeRA-301 trial readout.
Markets & Technology
Technology, computing, crypto and cannabis, and the listed companies moving in them.
View all
TechnologyAI and Autonomy
Digi Power X reports US$12.25M revenue as AI sales reach US$5.66M
Both headline growth rates compare with Q2, while Columbiana billing is expected to start in January 2027.
Bitcoin
NASDAQ: NAKANakamoto extends maturity on 60M USDT of Kraken debt to December 2027
The existing 165 million USDT balance remains due in 2027, while eligible positive net derivatives value can count toward collateral requirements.
Energy
Uranium, lithium, oil and gas, hydrogen and the grid: the fuels and the companies behind them.
View all
Energy
NYSE: BWXTOPG is reassessing Darlington's first SMR budget and schedule, with its assessment due to be substantially complete by mid-2027.
Energy
NYSE: OKLOPrepayments will help fund U.S. enrichment capacity, with enough HALEU for up to five Aurora powerhouses over multiple years.
Technology
NASDAQ: RNWThe proposed 1 GW facility accounts for most of the announced budget, but ReNew has disclosed neither financing terms nor a delivery date.
Cannabis & Psychedelics
Licensed producers, retail, policy, and the psychedelics companies moving through the clinic.
View all
Cannabis
TSE: LABSInternational medical sales supplied 59 per cent of quarterly revenue, while gross margin and adjusted EBITDA declined sequentially.
Cannabis
TSE: CURACanada and Germany have completed competition reviews, Curaleaf says, while its offer remains outstanding until Dec. 4.
Cannabis
CNSX: CLCThe board accepted its committee's recommendation on Oct. 26, citing the harvest, a stronger outlook and debt repayment.
Psychedelics
NASDAQ: CMPSThe submission draws on studies involving more than 1,000 participants, with a first-half 2027 launch still subject to FDA approval.